In vivo models for rabGEF1-dependent signaling and functions

Details In vivo models for rabGEF1-dependent signaling and functions In vivo models for rabGEF1-dependent signaling and functions

2008-04-29

2008-04-29

Paras, Jr., Peter (Department: 1632)

Multicellular living organisms and unmodified parts thereof and

Nonhuman animal

Transgenic nonhuman animal

C800S013000, C800S014000, C800S003000

Reexamination Certificate

active

07365239

ABSTRACT:
Non-human transgenic animal models and cells derived therefrom are provided for RabGEF1 function. RabGEF1 is a negative regulator of FcεRI-dependent mast cell activation and T cell activation via the T cell receptor and a lack of RabGEF1 results in the development of skin inflammation in vivo. The mast cells derived from such animals exhibit enhanced Ras-mediated signaling and functional responses when activated through high affinity IgE receptors. These cells show significant potentiation of IgE and antigen-dependent secretion of 3 classes of mast cell mediators, providing a useful source of mast cells for screening assays. The animals and cells derived therefrom are also useful for screening biologically active agents that may modulate RabGEF1 function, including therapeutic agents for the treatment of skin disorders, such as eczema, psoriasis, and the like, or for the treatment of other mast cell-associated disorders, including allergic disorders, such as asthma and hay fever, and certain autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis. Inhibiting RabGEF1 function may be useful in those conditions in which it is desirable to enhance T cell and/or mast cell function, such as in AIDS or other immune deficiency disorders.

REFERENCES:
patent: 5464764 (1995-11-01), Capecchi et al.
patent: 6500942 (2002-12-01), Tam et al.
Capeccehi, MR. Science 244:1288-1292, 1989.
Tam, SY, et al. Nature Immunology 5(8):844-852, 2004.
Sigmond, C. Art Thromb Vasc Biol 20:1425-1429, 2000.
Mullins, JJ and LJ Mullins. Hypertension 22:630-633, 1993.
Niemann, H. ransgenci Res 7:73-75, 1998.
Kappel, CA et al. Curr Opin Biotech 3:548-553, 1992.
Mullins, LJ and JJ Mullins. J Clin Invest 98(11):S37-S40, 1996.
Houdebine, LM. J Biotech 34:269-287, 1994.
Wall, RJ. Theriogenology 45:57-68, 1996.
Cameron, ER. Molec Biotech 7:253-265, 1997.
Horiuchi et al., A Novel RAB5 GDP/GTP Exchange Factor Complexed to Rabaptin-5 Links Nucleotide Exchange to Effector Recruitment and Function, NP—777016, Cell, 1997, 90(6): 1149-1159.
Katayama et al., Antisense Transcription in the Mammalian Tran Scriptome, NP—064367, Science, 2005, 309(5740): 1564-1566.
Mattera et al., Divalent Interaction of the GGAs With the Rabaptin-5 Rabex-5 Complex, NP—055319, Embo J., 2003, 22(1): 78-88.
Stausberg et al., Generation and Initial Analysis of More Than 15,000 Full-Length Human and Mouse CDNA Sequences, NP—957137, Proc. Natl. Acad. Sci., 2002, 99(26): 16899-16903.
Genbank Accession No. XP—341068, This record is predicted by automated computational analysis. This record is derived from an annotated genomic sequence(NW—047374) using gene prediction method: GNOMON, supported by mRNA evidence, Apr. 15, 2005.

Affiliated with

Also associated with

Rating

In vivo models for rabGEF1-dependent signaling and functions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with In vivo models for rabGEF1-dependent signaling and functions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In vivo models for rabGEF1-dependent signaling and functions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2773440